Allergy & Asthma Network, the leading voice in patient education and advocacy, announces the launch of a new awareness campaign to highlight the importance of good asthma control. The national ...
The Food and Drug Administration (FDA) has approved Breztri Aerosphere ® (budesonide/glycopyrrolate/formoterol fumarate; BGF) for the maintenance treatment of asthma in adult and ...
The FDA has approved a fixed-dose triple combination therapy for the maintenance treatment of asthma in adults and children aged 12 years and older, according to a press release from manufacturer ...
Verywell Health on MSN
GLP-1 drugs may cut asthma flare-ups in people with overweight or obesity
Medically reviewed by Patricia Mikula, PharmD Key Takeaways GLP-1 drugs were linked to a significant reduction in asthma ...
The FDA has approved AstraZeneca’s Breztri Aerosphere as the first maintenance triple therapy for asthma in patients aged 12 and older. The inhaler combines an inhaled corticosteroid, a long-acting ...
Managing asthma effectively requires more than just keeping an inhaler nearby. This chronic respiratory condition affects approximately 25 million Americans, yet despite medical advances and improved ...
VIENNA — Physicians are called to record clinical details of patients with asthma undergoing biologic therapy to monitor clinical remission and keep an eye on eosinophilic granulomatosis with ...
A new study published in the Journal of the American Medical Association (JAMA) found 33 per cent of adults recently diagnosed with asthma by their physicians did not have an active form of the ...
Timing transforms outcomes For people living with severe asthma, outcomes are not determined only by what treatment they ...
Underlying mood and sleep disorders may negatively affect asthma control, researchers find. “Asthma control, sleep quality, and mood are all critical factors in affecting an individual’s overall ...
Approximately one-third of asthma patients may actually not have the long-term inflammatory disease, according to new research published in JAMA. For the study, researchers recruited 701 participants ...
ATLANTA - Prices are rising sharply on many asthma inhalers just in time for spring allergy season and some insurance companies are not covering the higher costs, and many patients cannot afford the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results